| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-15 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |